Clinical Trial

Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to continuously assess cerebral autoregulation in patients with subarachnoid hemorrhage (SAH) using cerebral oximetry index (COx) and hemoglobin volume reactivity index (HVx). The main question it aims to answer is: Whether optimal perfusion pressure is dynamic and changes with time in patients with SAH, and that autoregulation is disrupted in patients during the course of SAH, contributing to delayed cerebral ischemia (DCI).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-04-10; most recent amendment 2026-07-13.
Trial Details
NCT Number NCT06932640
Lead Sponsor University of Alabama at Birmingham
Collaborators: Edwards Lifesciences
Conditions Subarachnoid Hemorrhage, Aneurysmal
Enrollment 120 participants
Start Date 2026-08-03
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-14